New diabetes clinical trial: A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes
Published on: April 24, 2025 at 11:00PM
Conditions: Healthy; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
Interventions: Drug: LY4057996 SC; Drug: LY4057996 IV; Drug: Placebo SC; Drug: Placebo IV; Drug: Degludec SC; Drug: Lispro SC; Drug: Degludec IV; Drug: Pre-study basal insulin SC
Sponsors: Eli Lilly and Company
Not yet recruiting
https://ift.tt/jiAXQ92
Conditions: Healthy; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
Interventions: Drug: LY4057996 SC; Drug: LY4057996 IV; Drug: Placebo SC; Drug: Placebo IV; Drug: Degludec SC; Drug: Lispro SC; Drug: Degludec IV; Drug: Pre-study basal insulin SC
Sponsors: Eli Lilly and Company
Not yet recruiting
https://ift.tt/jiAXQ92
Comments
Post a Comment